Overview
Precision Instruments

NIPRO CORPORATION

Nipro Corporation is a comprehensive medical manufacturer engaged in three core business segments: Medical Devices (including dialyzers/artificial kidneys, syringes, and medical equipment), Pharmaceuticals (generic drugs and pharmaceutical products), and Pharma Packaging (glass and plastic packaging for pharmaceutical use). The company also pursues regenerative medicine, including treatments for spinal cord injuries. Nipro serves global healthcare markets with proprietary products developed across four R&D centers, positioning itself as a 'truly global integrated medical manufacturer.'

Market Cap
¥223B
US$1.42B
EV
¥821B
US$5.23B
Stock¥1,343.5▲+0.22%
US$1 = ¥157.05 (2026-10-22)
LTM EV/EBITDA
8.3
x
LTM EV/EBIT
20.0
x
LTM PER
15.9
x
LTM PBR
0.8
x
Stock vs TOPIX (1Y, base=100)vs TOPIX ▼-35.2%pt
100
Oct 23, 25 – Oct 23, 26StockTOPIX
MC → EV Bridge
223BUS$1.42BMarket Cap662BUS$4.21B+ Debt105BUS$668M− Cash19.4BUS$123M− Inv. Sec.60.7BUS$386M+ NCI821BUS$5.23BEV
AI Briefing
Generating insights…
Performance & Balance
Revenue 5Y (¥B)
495US$3.15B'22/3545US$3.47B'23/3587US$3.74B'24/3645US$4.10B'25/3661US$4.21B'26/3
EBITDA 5Y (¥B)
67.2US$428M'22/364.0US$408M'23/378.4US$499M'24/389.1US$567M'25/399.3US$632M'26/3
Net Income 5Y (¥B)
13.5US$85.7M'22/34.57US$29.1M'23/311.1US$70.7M'24/35.11US$32.6M'25/313.5US$86.0M'26/3
Capital Structure
30%
70%
EquityD/E 2.34xDebt
Liquidity vs Debt 5Y (¥B)▼ Net Debt
CashInv. Sec.Debt
140US$894M559US$3.56B'22/3127US$808M596US$3.79B'23/3133US$844M630US$4.01B'24/3122US$777M632US$4.02B'25/3117US$743M638US$4.06B'26/3
Shareholders
Top 10 hold 40.6%
1
The Master Trust Bank of Japan, Ltd. (Trust Account)
10.70%
2
Custody Bank of Japan, Ltd. (Trust Account)
7.53%
3
Nippon Electric Glass Co.,Ltd.
5.19%
4
BNY GCM CLIENT ACCOUNT JPRD AC ISG (FE-AC; Standing Proxy: MUFG Bank, Ltd.)
3.68%
5
MACQUARIE FINANCIAL LIMITED (Standing Proxy: Citibank, N.A., Tokyo Branch)
3.11%
6
STATE STREET BANK AND TRUST COMPANY505223 (Standing Proxy: Mizuho Bank, Ltd.)
2.65%
7
JPMorgan Securities Japan Co., Ltd.
2.44%
8
Mizuho Securities Co., Ltd.
2.07%
9
NIPRO CORPORATION Employee Stock Ownership Association
1.61%
10
GOLDMAN SACHS INTERNATIONAL (Standing Proxy: Goldman Sachs Japan Co., Ltd.)
1.58%
Management
13 officers
Yoshihiko SANO
Representative Director, Chairman
Apr 1968 Joined Nippon Glass Fiber Co., Ltd. Nov 1975 Joined Nipro Corporation Feb 1993 Director, Deputy General Manager, Sales Division, Nipro Corporation Jun 2000 Director, General Manager, Sales Division, Nipro Corporation Jun 2000 Director of the Company Apr 2001 Director, Deputy General Manager, Domestic Business Division Jun 2006 Senior Managing Director, General Manager, Domestic Business Division May 2012 Representative Director, President, and General Manager, Domestic Business Division Jun 2012 Representative Director, President, and General Manager, Materials Business Division Oct 2012 Representative Director, President Jun 2025 Representative Director, Chairman (current)
1945-01-16
Tsuyoshi YAMAZAKI
Representative Director, President and Executive Officer
Apr 1991 Joined the Company Feb 2009 Deputy Manager, Nipro Brand Sales Department, International Business Division Jun 2009 Director, General Manager, Nipro Brand Sales Department, International Business Division Apr 2012 Director, General Manager, International Sales Department, International Business Division Jan 2014 Director, General Manager, Global Strategy Department, International Business Division Jul 2014 Director, General Manager, MP Glass Business Division Jan 2015 Director, General Manager, MP Glass Business Division, and General Manager, Global Strategy Office Apr 2016 Director, General Manager, Pharma Packaging Business Division, and General Manager, Global Strategy Office Apr 2018 President and Representative Director, Nipro Europe Group Companies N.V. Jun 2018 Managing Director, General Manager, Pharma Packaging Business Division, and General Manager, Global Strategy Office Apr 2020 Managing Director, General Manager, Pharma Packaging Business Division Jun 2020 Managing Director, General Manager, International Business Division, General Manager, Global Strategy Headquarters, and in charge of Pharma Packaging Business Division May 2021 Managing Director, General Manager, International Business Division, and in charge of Pharma Packaging Business Division Jul 2023 Senior Managing Director, Overall Supervisor of International Business, General Manager, International Business Division, and in charge of Pharma Packaging Business Division Jun 2025 Representative Director, President (current) Jun 2026 Representative Director, President and Executive Officer
1968-03-30
Takehito YOGO
Director, Senior Managing Executive Officer, Chief Financial Officer
Oct 1996 Joined Ota Showa & Co. (currently EY ShinNihon LLC) Apr 2000 Registered as Certified Public Accountant Mar 2004 General Manager, Internal Audit Office, Goodman Co., Ltd. (currently Nipro Vascular Co., Ltd.) Nov 2004 General Manager, Management Planning Office, the same company Feb 2005 Executive Officer, General Manager, Management Planning Office, the same company Sep 2006 Director, General Manager, Administration Division, the same company Jan 2009 Director, General Manager, Production Supervision Division, and General Manager, Administration Supervision Division, the same company Oct 2009 President and Representative Director, the same company Jun 2015 Director, Deputy General Manager, Management Planning Division, and General Manager, Management Planning Department, the Company Feb 2016 Director, General Manager, Management Planning Division, and General Manager, Management Planning Department Jun 2018 Managing Director, General Manager, Management Planning Division, and General Manager, Management Planning Department Apr 2020 Managing Director, General Manager, Management Planning Division Jul 2023 Senior Managing Director, Overall Supervisor of Financial Planning, General Manager, Management Planning Division Nov 2023 Senior Managing Director, Overall Supervisor of Administration, General Manager, Management Planning Division Jun 2025 Senior Managing Director, Chief Financial Officer (current) Jun 2026 Director, Senior Managing Executive Officer, Chief Financial Officer
1968-10-28
Kimito MINOURA
Director, Managing Executive Officer, Chief Operating Officer, and General Manager, Group DX Planning Office
Apr 1995 Joined the Company Apr 2005 Manager, Accounting Planning Department, Accounting Planning Section Jun 2009 Director, General Manager, Planning and Administration Department Jul 2014 Director, General Manager, Management Planning Division, and General Manager, Management Planning Department Jun 2015 Director, General Manager, Management Planning Division, and General Manager, Product Planning Division, Planning, Development and Technology Business Division Feb 2016 Director, General Manager, Product Planning Division, Planning, Development and Technology Business Division Apr 2017 Director, General Manager, New Business Development Division Apr 2018 Director, General Manager, Cell Products Business Division, and General Manager, New Business Development Division Jun 2018 Managing Director, General Manager, Cell Products Business Division, and General Manager, New Business Development Division Aug 2018 Managing Director, General Manager, Regenerative Medicine Business Division, and General Manager, New Business Development Division Sep 2022 Managing Director, General Manager, Regenerative Medicine Business Division, General Manager, Business Promotion Division, and General Manager, New Business Development Division Apr 2024 Managing Director, General Manager, Regenerative Medicine Business Division, General Manager, Business Promotion Division, General Manager, Business Management Division, and General Manager, New Business Development Division Jun 2025 Managing Director, Overall Supervisor of Value Engineering, in charge of Regenerative Medicine Business Division, General Manager, Group DX Planning Office, and General Manager, New Business Development Division Oct 2025 Managing Director, Overall Supervisor of Value Engineering, General Manager, Group DX Planning Office, and General Manager, New Business Development Division May 2026 Managing Director, Overall Supervisor of Value Engineering, General Manager, Group DX Planning Office (current) Jun 2026 Director, Managing Executive Officer, Chief Operating Officer, and General Manager, Group DX Planning Office
1972-10-12
Yasushi OYAMA
Director, Managing Executive Officer, Chief Innovation Officer, General Manager, Global Innovation Division, and Managing Executive Officer in charge of Vascular Business
Feb 2002 Joined Zimmer Medizinsysteme Japan K.K. Mar 2003 Joined the Company Apr 2009 Deputy Manager, Vascular Product Development and Sales Department, Product Development and Sales Division, Domestic Business Division Apr 2011 General Manager, Vascular Product Development and Sales Department, Product Development and Sales Division, Domestic Business Division Feb 2013 General Manager, Vascular Business Unit, Domestic Business Division Jun 2013 Director, General Manager, Vascular Business Unit, Domestic Business Division Oct 2014 Director, General Manager, Vascular Business Unit, Planning, Development and Technology Business Division Apr 2015 Director, General Manager, Vascular Business Division Jun 2015 President and Representative Director, Goodman Co., Ltd. (currently Nipro Vascular Co., Ltd.) Apr 2018 Director, General Manager, Vascular Business Division, and General Manager, Vascular Product Development and Sales Division Jun 2018 Managing Director, General Manager, Vascular Business Division, and General Manager, Vascular Product Development and Sales Division Apr 2024 Managing Director, General Manager, Vascular Business Division Apr 2026 Managing Director, General Manager, Global Innovation Division, and Managing Executive Officer in charge of Vascular Business (current) Jun 2026 Director, Managing Executive Officer, Chief Innovation Officer, General Manager, Global Innovation Division, and Managing Executive Officer in charge of Vascular Business
1962-12-14
Toshikazu YOSHIMORI
Director
Apr 1998 Branch Manager, Tsukiji Branch and Tsukishima Branch, Sakura Bank, Ltd. (currently Sumitomo Mitsui Banking Corporation) Apr 2000 Branch Manager, Shinbashi-Higashi Branch, the same bank Apr 2002 General Manager, Ginza Corporate Sales Department, the same bank Nov 2002 Advisor, Horai Co., Ltd. Dec 2002 Director, General Manager, Insurance Business Division, and General Manager, Real Estate Business Division, the same company Oct 2003 Managing Director, General Manager, President's Office, General Manager, Insurance Business Division, and General Manager, Real Estate Business Division, the same company Dec 2008 Senior Managing Director and Senior Executive Officer, General Manager, General Planning Department, General Manager, Insurance Business Division, General Manager, Tokyo Insurance Department, Insurance Business Division, in charge of Accounting Department and System Office, the same company Aug 2012 Senior Managing Director and Senior Executive Officer, General Manager, Insurance Business Division, General Manager, Tokyo Insurance Department, Insurance Business Division, in charge of General Planning Department, Accounting Department and System Office, the same company Dec 2013 Advisor, Murouchi Building Co., Ltd. Oct 2014 Director, Japan Health Insurance Association Apr 2015 Member, Central Social Insurance Medical Council Oct 2021 Member, Long-Term Care Insurance Subcommittee, and Member, Long-Term Care Benefit Subcommittee, Social Security Council Jun 2024 Director of the Company (current) Apr 2026 Member, Nomination and Compensation Committee of the Company (current)
1951-11-08
Yasuhiko IMAIZUMI
Director
Apr 2008 Executive Officer, General Manager, Nagoya Business Division, Mizuho Corporate Bank, Ltd. (currently Mizuho Bank, Ltd.) Apr 2010 Managing Executive Officer, in charge of Sales, the same bank Apr 2012 Managing Executive Officer, Deputy Head of Branch Sales, the same bank Apr 2013 Deputy President and Executive Officer, in charge of Large Corporate Unit, Business Corporate Unit, and Financial and Public Institutions Unit, Mizuho Financial Group, Inc.; Deputy President, Mizuho Bank, Ltd.; Director (Representative), Deputy President and Executive Officer, in charge of Large Corporate Unit, Business Corporate Unit, and Financial and Public Institutions Unit, Mizuho Corporate Bank, Ltd. Jul 2013 Director (Representative), Deputy President and Executive Officer, in charge of Large Corporate Unit, Business Corporate Unit, and Financial and Public Institutions Unit, Mizuho Bank, Ltd. Apr 2014 Director (Representative), Deputy President and Executive Officer, in charge of Corporate Sales, Mizuho Securities Co., Ltd. Apr 2016 Chairman of the Board, the same company Jun 2018 Director, Deputy President and Executive Officer, General Manager, Business Promotion Division, Nippon Steel & Sumikin Real Estate Co., Ltd. (currently Nippon Steel Kowa Real Estate Co., Ltd.) Apr 2019 Representative Director, President and Executive Officer, the same company Apr 2023 Director, Senior Advisor, the same company Jun 2023 Senior Advisor, the same company Jun 2023 Outside Director, Nippon Seisen Co., Ltd. (current) Jun 2024 Director of the Company (current) Jul 2024 Outside Director, Kozo Keikaku Engineering Holdings Inc. (current) Apr 2026 Member, Nomination and Compensation Committee of the Company (current)
1956-09-27
Takayuki NOMIYA
Standing Audit & Supervisory Board Member
Apr 1967 Joined Taisho Pharmaceutical Co., Ltd. Oct 1976 Joined the Company Apr 1997 General Manager, General Affairs Department Feb 2003 General Manager, Internal Audit Office Feb 2008 Resigned from the Company Jun 2008 Audit & Supervisory Board Member of the Company (current)
1943-02-01
Toshinobu MORIMOTO
Standing Audit & Supervisory Board Member
Apr 1985 Joined the Company Apr 2005 Manager, Sales Promotion Section, Medical Promotion Department, Device Development Division, the Company Dec 2011 Manager, Pharmaceutical Research Laboratory, Management Section Apr 2013 Deputy Manager, Internal Audit Office Apr 2015 General Manager, Internal Audit Office Jun 2021 Executive Officer, General Manager, Internal Audit Office Jun 2025 Audit & Supervisory Board Member of the Company (current)
1961-08-15
Shigeru YANAGASE
Audit & Supervisory Board Member
Apr 2003 General Manager, Development Department, Specialty Materials Business Division, Nippon Sheet Glass Co., Ltd. Jul 2007 Resigned from Nippon Sheet Glass Co., Ltd. Jun 2015 Substitute Audit & Supervisory Board Member of the Company Jun 2016 Substitute Audit & Supervisory Board Member of the Company Jun 2017 Substitute Audit & Supervisory Board Member of the Company Jun 2018 Substitute Audit & Supervisory Board Member of the Company Jun 2019 Substitute Audit & Supervisory Board Member of the Company Jun 2020 Substitute Audit & Supervisory Board Member of the Company Jun 2021 Substitute Audit & Supervisory Board Member of the Company Jun 2022 Substitute Audit & Supervisory Board Member of the Company Jun 2023 Audit & Supervisory Board Member of the Company (current)
1947-05-02
Masataka AKIKUNI
Audit & Supervisory Board Member
Jul 2001 General Manager, Pension Trust Investment Department, Trust Asset Management Department, Daiwa Bank, Ltd. (currently Resona Bank, Ltd.) Jun 2006 Executive Officer, General Manager, Trust Asset Management Department, Resona Trust & Banking Co., Ltd. (currently Resona Bank, Ltd.) Apr 2008 Executive Officer, in charge of General Funds Department, Resona Bank, Ltd. Jun 2009 Managing Executive Officer, J&S Insurance Service Co., Ltd. Apr 2011 Supervisor, Osaka Electro-Communication University Jun 2011 Outside Audit & Supervisory Board Member, Japan Trustee Services Bank, Ltd. (currently Japan Custody Bank, Ltd.) Jun 2012 Outside Audit & Supervisory Board Member, Fuso Chemical Co., Ltd. Jun 2014 Outside Audit & Supervisory Board Member, Kokusai Aeromarine Co., Ltd. Jun 2015 Outside Audit & Supervisory Board Member, Ishihara Sangyo Kaisha, Ltd. Jun 2023 Audit & Supervisory Board Member of the Company (current)
1953-09-21
Toshiaki HATTORI
Director
Jan 2000 Branch Manager, Kōri Branch, Daiwa Bank, Ltd. (currently Resona Bank, Ltd.) Mar 2002 Branch Manager, Taisho Branch, Resona Bank, Ltd. Jun 2004 General Manager, General Affairs Department, Administration Division, Toami Corporation Jun 2006 Director, General Manager, General Affairs Department, the same company Jun 2008 Managing Director, General Manager, Administration Division, and General Manager, General Affairs Department, the same company Jun 2012 Managing Director, General Manager, Administration Division, General Manager, General Affairs Department, and General Manager, Accounting Department, the same company Jun 2022 Director of the Company (current) Apr 2026 Member, Nomination and Compensation Committee of the Company (current)
1954-06-03
Mikako TANAKA
Director
Jan 1991 Manufacturing IT Group Manager, Global Business Unit Asia Pacific, The Procter & Gamble Company Jun 2002 IT Director, GE Aircraft Engine Japan (currently GE Aerospace Japan) Jun 2002 IT Manager, Johnson & Johnson Jun 2004 Senior Director, Head of IT, Tiffany & Co. Nov 2008 Head of IT and Head of Crisis Management, L'Oréal Japan, Inc. Jan 2018 Executive Officer, CIO, AstraZeneca K.K. Jan 2021 Executive Officer, CIO, ORIX Corporation Japan (Trustee), ORIX Auto Corporation, and Rentec Corporation Sep 2022 Managing Director, Technology Consulting, Accenture K.K. Oct 2025 Consulting Managing Partner, Gartner Japan, Ltd. Jun 2026 Director of the Company
1967-10-28
Large Shareholding Reports
Goldman Sachs International
2026-10-22
4.15%→4.46%
Nomura Asset Management Co., Ltd.
2026-10-07
3.10%→3.12%
Nomura Asset Management Co., Ltd.
2026-09-25
1.43%→3.10%
Mizuho Securities Co., Ltd.
2026-09-07
3.23%→2.05%
Annual report (as of 2026-03-31): 2.07%
Nomura Securities Co., Ltd.
2026-07-07
4.73%→4.74%
Nomura Securities Co., Ltd.
2026-06-22
5.63%→4.73%
Goldman Sachs International
2026-06-05
4.15%
Mizuho Securities Co., Ltd.
2026-05-22
3.95%→4.01%
Annual report (as of 2026-03-31): 2.07%
Goldman Sachs International
2026-05-22
4.74%→4.07%
NOMURA SECURITIES CO., LTD.
2026-05-22
5.69%→5.63%
Nomura Securities Co., Ltd.
2026-04-22
5.70%→5.69%
Nomura Securities Co., Ltd.
2026-04-07
5.68%→5.70%
Mizuho Securities Co., Ltd.
2026-04-07
4.38%→3.95%
Annual report (as of 2026-03-31): 2.07%
Nippon Electric Glass Co., Ltd.
2026-03-06
5.96%→4.96%
Annual report (as of 2026-03-31): 5.19%
Nomura Securities Co., Ltd.
2026-03-06
5.74%→5.68%
Nomura Securities Co., Ltd.
2026-01-08
5.67%→5.74%
Mizuho Securities Co., Ltd.
2025-11-21
4.38%
Annual report (as of 2026-03-31): 2.07%
NOMURA SECURITIES CO., LTD.
2025-10-21
5.66%→5.67%
Mizuho Securities Co., Ltd.
2025-09-22
3.47%→2.12%
Annual report (as of 2026-03-31): 2.07%
Nomura Securities Co., Ltd.
2025-09-22
5.69%→5.66%
Mizuho Securities Co., Ltd.
2025-09-05
3.41%→3.47%
Annual report (as of 2026-03-31): 2.07%
Nomura Securities Co., Ltd.
2025-09-05
5.74%→5.69%
Disclosures
No disclosures
Primary Source Filings
EDINET
2026-10-22
Large Shareholding Report
EDINET
2026-10-07
Large Shareholding Report
EDINET
2026-09-25
Large Shareholding Report
EDINET
2026-09-07
Large Shareholding Report
TDnet
2026-08-10
Q1 Earnings Flash
FY ending Mar 2027
EDINET
2026-07-07
Large Shareholding Report
EDINET
2026-06-25
Annual Securities Report
Period: Apr 2025 – Mar 2026
EDINET
2026-06-22
Large Shareholding Report
EDINET
2026-06-05
Large Shareholding Report
EDINET
2026-05-22
Large Shareholding Report
EDINET
2026-05-22
Large Shareholding Report
EDINET
2026-05-22
Large Shareholding Report
EDINET
2026-04-22
Large Shareholding Report
EDINET
2026-04-07
Large Shareholding Report
EDINET
2026-04-07
Large Shareholding Report
EDINET
2026-03-06
Large Shareholding Report
EDINET
2026-03-06
Large Shareholding Report
TDnet
2026-02-09
Q3 Earnings Flash
FY ending Mar 2026
EDINET
2026-01-08
Large Shareholding Report
EDINET
2025-11-21
Large Shareholding Report
EDINET
2025-11-14
Semi-Annual Securities Report
Period: Apr 2025 – Mar 2026
EDINET
2025-10-21
Large Shareholding Report
EDINET
2025-09-22
Large Shareholding Report
EDINET
2025-09-22
Large Shareholding Report
EDINET
2025-09-05
Large Shareholding Report
EDINET
2025-09-05
Large Shareholding Report
TDnet
2025-08-08
Q1 Earnings Flash
FY ending Mar 2026
EDINET
2025-06-25
Annual Securities Report
Period: Apr 2024 – Mar 2025
TDnet
2025-02-07
Q3 Earnings Flash
FY ending Mar 2025
EDINET
2024-11-14
Semi-Annual Securities Report
Period: Apr 2024 – Mar 2025
Ask AI
I have this company's financials, ownership, and management on hand. Ask me anything from an M&A perspective.
End of Preview

Try the full product

Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.

Free Demo (No Time Limit, 10 Companies) →